Bio-IT World February 20, 2020
Contributed Commentary By Matthew Michela, President and CEO, Life Image and Dan Housman, Co-founder and CTO, Graticule
Radiology is increasingly the key to synthesizing real world evidence with sufficient quality to shape drug performance. As a diagnostic toolset, imaging is one of the oldest and most widely used and clearly interpreted methods for measurement of outcomes. It is regularly used to measure disease progression and to determine the effectiveness of medical interventions. For example, in neurology, imaging is used to determine progression in Multiple Sclerosis by establishing plaque accumulation over time. In oncology, imaging is used to measure solid tumor size and burden in response to or preparation for therapy. Imaging is also a common mechanism...
Today's Sponsors
Today's Sponsor